Results 301 to 310 of about 9,364,051 (364)

Comment on "Burden of coeliac disease in Germany: real-world insights from a large retrospective health insurance claims database analysis". [PDF]

Therap Adv Gastroenterol
Marta B, Monia B, Francesco V.
europepmc   +1 more source

Editorial: Peering through the fog—New tools to assess neurocognitive symptoms in coeliac disease [PDF]

Javier Villafuerte-Gálvez, Daniel A. Leffler   +1 more
openalex   +1 more source

Cerebral Thrombophlebitis Complicating Coeliac Disease. [PDF]

Cureus
Zouiter S, Bensabbahia D, Atrassi M, Abkari A.   +3 more
europepmc   +1 more source

The immune recognition of gluten in coeliac disease

, 2005
Rachele Ciccocioppo, Antonio Di Sabatino, Gino Roberto Corazza   +2 more
openalex   +2 more sources

Comparison of ultrasound with computed tomography and whole‐body diffusion‐weighted MRI in prediction of surgical outcome using ESMO‐ESGO criteria in patients with tubo‐ovarian carcinoma: prospective ISAAC study

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 2, Page 207-219, February 2026.
ABSTRACT Objective To test the non‐inferiority of extended abdominopelvic ultrasound examination compared with contrast‐enhanced computed tomography (CT) and whole‐body diffusion‐weighted magnetic resonance imaging (WB‐DWI/MRI) in discriminating preoperatively between resectable and non‐resectable disease based on the European Society for Medical ...
D. Fischerova, P. Pinto, J. L. Alcázar Zambrano, J. Vara‐Garcia, V. Chiappa, F. Raspagliesi, D. Franchi, A. V. Urbinati, A. C. Testa, J. Jarkovsky, D. Cibula, F. Moro, Collaborators, F. Frühauf, J. Slama, R. Kocian, S. Alessi, G. Avesani, K. Benesova, A. Burgetova, G. Calareso, L. Lambert, M. Masek, A. Fagotti, C. Panico, P. Pricolo, R. Vigorito   +26 more
wiley   +1 more source

An optimised whole blood interleukin-2 release assay is more sensitive than interferon-γ ELISpot for detecting and quantifying gluten-specific CD4⁺ T-cell responses in coeliac disease. [PDF]

Clin Transl Immunology
Moscatelli OG, Russell AK, Henneken LM, Hardy MY, Tye-Din JA.   +4 more
europepmc   +1 more source

Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 4, Page 557-568, February 2026.
One in five people with Rome IV irritable bowel syndrome use opioids on a regular basis. Compared with non‐users, opioid users had worse quality of life, greater psychological impairment, and higher direct healthcare costs. ABSTRACT Background The United Kingdom (UK) has one of the highest worldwide opioid prescription rates per capita.
Mohsin F. Butt, Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black, Alexander C. Ford, Maura Corsetti, Peter Paine   +6 more
wiley   +1 more source

Interpretable Machine Learning based Detection of Coeliac Disease

Jaeckle F, Bryant R, Denholm J, Diaz JR, Schreiber B, Shenoy V, Ekundayomi D, Evans SC, Arends MJ, Soilleux E.   +9 more
europepmc   +1 more source

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura, Magdalena Piotrowska‐Mieczkowska, Matylda Hennig, Mateusz Gliwiński, Anna Wołoszyn‐Durkiewicz, Julia Schoenhoff, Milena Dybowska, Anna Alska, Piotr Gutknecht, Bartosz Trzeciak, Katarzyna Stefańska, Paulina Glasner, Marcin Hellmann, Jacek Burzyński, Arkadiusz Michalak, Janusz Siebert, Dorota Iwaszkiewicz‐Grześ, Małgorzata Myśliwiec, Piotr Trzonkowski   +18 more
wiley   +1 more source

EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia

European Journal of Neurology, Volume 33, Issue 2, February 2026.
ABSTRACT Background Recent epidemiological studies on the general population reveal that up to 1.3% have oligo/asymptomatic hyperCKemia. Objective This guideline aims to provide updated, evidence‐based recommendations on investigating persons older than 18 years.
T. Kyriakides, K. Aleksovska, C. Angelini, Z. Argov, K. G. Claeys, M. de Visser, M. FIlosto, I. Jovanovic, A. Kostera‐Pruszczyk, M. J. Molnar, S. Sacconi, J. Schaefer, G. Siciliano, J. J. Vilchez, B. Schoser, A. Toscano   +15 more
wiley   +1 more source